These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6851871)

  • 21. Ifosfamide-based combination chemotherapy in advanced non-small cell lung cancer: two phase I studies.
    Hoffman PC; Masters GA; Drinkard LC; Krauss SA; Samuels BL; Golomb HM; Vokes EE
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):11-5. PubMed ID: 8677441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experience of a German multicenter study group with ifosfamide in small cell lung cancer.
    Havemann K; Wolf M; Drings P; Hans K; Schroeder M; Holle R; Flechtner H; Goerg R; Becker H
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):9-18. PubMed ID: 2539648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A phase II Gynecologic Oncology Group trial of ifosfamide and mesna in advanced or recurrent adenocarcinoma of the endometrium.
    Sutton GP; Blessing JA; DeMars LR; Moore D; Burke TW; Grendys EC
    Gynecol Oncol; 1996 Oct; 63(1):25-7. PubMed ID: 8898163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Phase II study of a three-drug combination of ifosfamide, cisplatin and vindesine in non-small-cell lung cancer].
    Ohnoshi T; Hiraki S; Ueoka H; Tamura T; Kawahara S; Yonei T; Yamashita H; Ishii J; Tamai M; Egawa T
    Gan To Kagaku Ryoho; 1988 Jan; 15(1):115-9. PubMed ID: 2827585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
    Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
    Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction chemotherapy with the TIP regimen (paclitaxel/ifosfamide/cisplatin) in stage III non-small cell lung cancer.
    Pohl G; Krajnik G; Malayeri R; Müller RM; Klepetko W; Eckersberger F; Schäfer-Prokop C; Pokrajac B; Schmeikal S; Maier A; Ambrosch G; Woltsche M; Minar W; Pirker R
    Lung Cancer; 2006 Oct; 54(1):63-7. PubMed ID: 16926060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A phase I-phase II study of vinorelbine with cisplatin, 5-fluorouracil, and leucovorin for advanced non-small cell lung cancer.
    Masters GA; Drinkard LC; Hoffman PC; Lane N; Watson S; Samuels BL; Bitran JD; Golomb HM; Vokes EE
    Cancer J Sci Am; 1995; 1(4):288-94. PubMed ID: 9166490
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical study of combination chemotherapy with cisplatin, ifosfamide, 5-FU (CIF therapy) of inoperable adenocarcinoma and large cell carcinoma of the lung].
    Fujita A; Sasaki H; Mori T; Nakajima S; Sekine K; Inoue Y; Honda R; Asakawa M; Suzuki A
    Gan To Kagaku Ryoho; 1991 Jan; 18(1):51-5. PubMed ID: 1846283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Combination chemotherapy with etoposide, mitomycin C, and cyclophosphamide in advanced non-small cell lung cancer].
    Homma T; Yoneda S; Fukuda Y; Nakata M; Noguchi Y; Yoshida S
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2399-403. PubMed ID: 3015045
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Polychemotherapy in inoperable bronchial carcinoma].
    Schmidt CG
    Strahlentherapie; 1984 Feb; 160(2):71-6. PubMed ID: 6328699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of intravenous hyperalimentation as an adjunct to intensive chemotherapy for small cell bronchogenic carcinoma.
    Valdivieso M; Bodey GP; Benjamin RS; Barkley HT; Freeman MB; Ertel M; Smith TL; Mountain CF
    Cancer Treat Rep; 1981; 65 Suppl 5():145-50. PubMed ID: 6809324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cytostatic treatment of hypernephroid renal carcinoma (author's transl)].
    König HJ; Hartwich G
    Dtsch Med Wochenschr; 1980 Dec; 105(52):1810-4. PubMed ID: 7449648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urinary excretion of ifosfamide, 4-hydroxyifosfamide, 3- and 2-dechloroethylifosfamide, mesna, and dimesna in patients on fractionated intravenous ifosfamide and concomitant mesna therapy.
    Kurowski V; Wagner T
    Cancer Chemother Pharmacol; 1997; 39(5):431-9. PubMed ID: 9054957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemotherapy for bronchogenic carcinoma. Methotrexate, doxorubicin, cyclophosphamide, and lomustine.
    Chahinian PA; Arnold DJ; Cohen JM; Purpora DP; Jaffrey IS; Teirstein AS; Kirschner PA; Holland JF
    JAMA; 1977 May; 237(22):2392-6. PubMed ID: 576939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chemotherapy with mitomycin C, vindesine and ifosfamide in the treatment of inoperable non-small cell bronchial carcinoma].
    Gatzemeier U; Hossfeld DK; Radenbach D; Zschaber R
    Onkologie; 1985 Aug; 8(4):208-12. PubMed ID: 3005935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ifosfamide with mesna uroprotection in the management of lung cancer.
    Holoye PY; Glisson BS; Lee JS; Dhingra HM; Murphy WK; Umsawasdi T; Levy JK; Jeffries D; Raber MN; Hong WK
    Am J Clin Oncol; 1990 Apr; 13(2):148-55. PubMed ID: 2156418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Integrated chemotherapy and radiotherapy of inoperable bronchial carcinoma: preliminary results in 50 cases (author's transl)].
    Seeber S; Schmidt CG; Holfeld H; Scherer E
    Dtsch Med Wochenschr; 1977 Feb; 102(5):147-52. PubMed ID: 832600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of ifosfamide-induced urothelial toxicity by oral administration of sodium 2-mercaptoethane sulphonate (MESNA) to patients with inoperable lung cancer.
    Araujo CE; Tessler J
    Eur J Cancer Clin Oncol; 1983 Feb; 19(2):195-201. PubMed ID: 6402369
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metastatic non-oat-cell bronchogenic carcinoma. Therapy with cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).
    Bitran JD; Desser RK; DeMeester T; Golomb HM
    JAMA; 1978 Dec; 240(25):2743-6. PubMed ID: 713008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.